Da un ricerca sul mechanismo della miltefosine sul promastigote di leishmania donovani, pubblicato nel 2004 risulta la prova che miltefosine è un

Similar documents
Miltefosine Affects Lipid Metabolism in Leishmania donovani Promastigotes

Design and Antileishmanial Activity of Amphotericin B-Loaded Stable Ionic Amphiphile Biovector Formulations

ACCEPTED. Philippe M. Loiseau c, Gillian Barratt a* Paris-Sud 11, Faculté de Pharmacie, IFR 141, Châtenay-Malabry, F France

Int.J.Curr.Res.Aca.Rev.2017; 5(4):

INIBITORE di BRAF nel MELANOMA

Authors Chappuis, François; Alirol, Emilie; Worku, Dagemlidet T; Mueller, Yolanda; Ritmeijer, Koert

Miltefosine induces metacaspase and PARP genes expression in Leishmania infantum

Mechanistic Studies of Pentamidine Analogs on Leishmania donovani Promastigotes

Aloe vera leaf exudate induces a caspaseindependent cell death in Leishmania donovani promastigotes

Ultrapure laser-synthesized Si-based nanomaterials for biomedical. applications: in vivo assessment of safety and biodistribution

Suture antibatteriche: mito o realtà? Michele Zuolo U.O Chirurgia Generale Ospedale «Valli del Noce» Cles Direttore: Dott. M.

ANRS CO12 CIRVIR - Prospective cohort involving patients with viral cirrhosis B and C

COST Action CM1307 conference

Identification and characterization of genes responsive to apoptosis: Application of DNA chip technology and mrna differential display

Farmacogenetica della terapia antidolorifica. Giovanni Gambassi Università Cattolica Sacro Cuore, Roma

Cours Pasteur. Molecular Cancer Genetics. September 24 October 5, Directors Jean-Pierre VARTANIAN Institut Pasteur. Sarah WATSON Institut Curie

Emergence of carbapenemase-producing Enterobacteriaceae in France, 2004 to 2011.

Impavido. (miltefosine) New Product Slideshow

Possible Mechanism of Miltefosine-Mediated Death of Leishmania donovani

Molecular switches between apoptosis and autophagy. 15_bmca_2011

TEXT 3 - CORREZIONE 047SL Traduzione inglese 3

ESEMeD/MHEDEA The European Study of the Epidemiology of Mental Disorders/Mental Health Disability : a

Series Editors Samuel J. Black, University of Massachusetts, Amherst, MA, US.A. J. Richard Seed, University of North Carolina, Chapel Hill, NC, US.A.

Cours Pasteur. Molecular Cancer Genetics. September 18-29, 2017

Akt targeting as a strategy to boost chemotherapy efficacy in non-small cell lung cancer through metabolism suppression.

Radiobiologia: High dose per fraction. Lidia Strigari Laboratorio di Fisica Medica e Sistemi Esperti SBRT

Membrane Fluidity Changes Are Associated with Benzo[a]Pyrene-Induced Apoptosis in F258 Cells

Alterazioni farmacocinetiche e farmacodinamiche (PK/PD) associate all età

Libri Personal Trainer

Pro-apoptotic effect of the landrace Bangla Mahoba of Piper betle on Leishmania donovani may be due to the high content of eugenol

Miltefosine (Hexadecylphosphocholine) Inhibits Cytochrome c Oxidase in Leishmania donovani Promastigotes

New insights on leishmaniasis in immunosuppressive conditions

Determination of the temporal pattern and importance of BALF1 expression in Epstein-Barr viral infection

Efficacies of Vesicular and Free Sodium Stibogluconate Formulations against Clinical Isolates of Leishmania donovani

on November 20, 2018 by guest

EVALUATION OF MILTEFOSINE AGAINST LEISHMANIA MAJOR (MRHO/IR/75/ER): IN VITRO AND IN VIVO STUDIES

Haut Conseil de la santé publique - French High Council for Public Health OPINION

In vitro and in vivo leishmanicidal studies of Peperomia galioides (Piperaceae)

Caractérisation et méthodes d études de la mort cellulaire par cytométrie en flux

Article available at or

16/06/2014. Introduzione I motivi di uno studio visti da un clinico. Riccardo Pistelli Università Cattolica - Roma

Medical Science. Jyoti Joshi, Sukhbir Kaur RESEARCH

Nanomedicine & Drug Delivery Systems Group Research Institute for Medicines and Pharmaceutical Sciences (imed.ul)

Translational PK M&S for the assessment of duration of contraceptive cover after use of miltefosine for the treatment of visceral leishmaniasis

Pharmacokinetics of daptomycin in a patient with severe renal failure not under dialysis

Evoluzione dello screening cervicale e ruolo del GISCI. Silvia Franceschi, CRO, Aviano NO CONFLICTS OF INTEREST

UNIVERSITY OF CALCUTTA

APOPTOSIS, NECROSIS AND CANCER. Dr. S. P. Pattanayak

Trattamenti locali nel NSCLC metastatico Integrazione con i trattamenti sistemici

Received 23 April 2009/Returned for modification 10 June 2009/Accepted 15 June 2009

CHARACTERIZATION OF V36C, A NOVEL AMINO ACID SUBSTITUTION CONFERRING HEPATITIS C VIRUS (HCV) RESISTANCE TO TELAPREVIR, A

PRESENTAZIONE DI RUGGERO DE MARIA

Quality of meta-analyses and why they sometimes lead to different conclusions

SUPPLEMENTARY DATA. Biologie and Pathology, Grenoble, France,

Vortioxetina: evidenze sui sintomi cognitivi della depressione. Umberto Albert

Apoptosis caused by Hsp90 inhibitor geldanamycin

Cuore. Materiale grafico di supporto alla lezione Estratto da: Bioelectromagnetism cap. 6,15,19

Revised AAC Version 2» New-Data Letter to the Editor ACCEPTED. Plasmid-Mediated Carbapenem-Hydrolyzing β-lactamase KPC-2 in

HCV eradication with direct acting antivirals (DAAs)? Why is viral cure possible in HCV? Emilie Estrabaud

Perché le malattie respiratorie sono sottodiagnosticate. S. Harari

Multi-clonal origin of macrolide-resistant Mycoplasma pneumoniae isolates. determined by multiple-locus variable-number tandem-repeat analysis

Received: 11 th August-2012 Revised: 14 th Sept-2012 Accepted: 16 th Sept-2012 Research article

Adverse Effects of Amphotericin B in Patients of Visceral Leishmaniasis: A Short Survey at Research Hospital Patna

The WORDS. The Autobiography Of Jean-Paul Sartre. Translated From The French By Bernard Frechtman. By Jean-Paul [ ].

La terapia empirica nelle infezioni micotiche

Mechanism of Amphotericin B Resistance in Leishmania donovani Promastigotes

Input of proteomics in nanoparticles toxicology: the example of macrophages responses to mineral nanoparticles

In-vitro susceptibility of Mycobacterium tuberculosis to trimethoprim and. sulfonamides, France

Inertial measurement units features to assess gait quality in aging or pathological states : a systematic review.

Accepted Manuscript. Building a scale for measuring burden of hand eczema: BoHEM

MANAGEMENT DELL IPERTENSIONE NEL VERY OLD FRAIL: PRESENTAZIONE DEL DOCUMENTO CONGIUNTO EUGMS-ESH

Tatiana El Hage 1,2,Séverine Lorin 3, Paulette Decottignies 4,5, Mojgan Djavaheri-Mergny 6 and François Authier 1,2

Pharmacokinetics of simultaneously administered antileishmanial and antiretroviral drugs. Ethiopia

Title: Treatment failure and miltefosine susceptibility in dermal leishmaniasis

He also gave what the judge found to be. expert, using Bayes theorem, made what the judge believed were poor calculations

Skin and soft tissue (SSTI) sepsis (surgery, antimicrobial therapy and more)

Small-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy

An Alternate, Egg-Free Radiolabeled Meal Formulation for Gastric-Emptying Scintigraphy

Prof.ssa Carmen Mortellaro

Farmaci bone-targeted: basi biologiche e razionale d uso. Giovanni Pavanato Rovigo

Interna'onal congress on Cancer cell death and resistance

Hexadecylphosphocholine: Oral Treatment of Visceral Leishmaniasis in Mice

PDF of Trial CTRI Website URL -

Journal Club: The Use of Fish Oil Lipid Emulsion for Gastrointestinal Surgery Patients

Introduction to pathology lecture 5/ Cell injury apoptosis. Dr H Awad 2017/18

Received 16 March 2017; returned 21 March 2017; revised 10 July 2017; accepted 11 July 2017

POST KALA-AZAR DERMAL LEISHMANIASIS WITH ULCERATION ON FOOT: AN ATYPICAL CASE PRESENTATION SUCCESSFULLY TREATED WITH MILTEFOSINE

Therapy of Visceral Leishmaniasis Due to Leishmania infantum: Experimental Assessment of Efficacy of AmBisome

Therapy of Visceral Leishmaniasis Due to Leishmania infantum: Experimental Assessment of Efficacy of AmBisome

Exercise Intolerance And Muscle Contracture By Georges Serratrice

Skills in Urban Economics, William Strange

Visceral leishmaniasis: an endemic disease with global impact

Non-medicinal Treatment of Cutaneous Leishmaniasis

Course Title Form Hours subject

Benzodiazepine abuse code

HLA, tra immunità innata e adattativa

ACCEPTED. Comparison of disk diffusion and agar dilution methods for erythromycin and

VARIABILE DI RISPOSTA

Therapeutic Modalities of Squalenoyl Nanocomposites in Colon Cancer: An Ongoing Search for Improved Efficacy

Fattori prognostici in SICU

Transcription:

Da un ricerca sul mechanismo della miltefosine sul promastigote di leishmania donovani, pubblicato nel 2004 risulta la prova che miltefosine è un potente farmaco orale contro la leishmania viscerale. il mechanismo tossico sul promastigote sarebbe indiretto al contrario di altri farmaci antileishmania con un effetto diretto e più rapido. Cioè il farmaco induce una specie di suicidio di massa delle cellule della leishmania. Le cellule si restringano e prendano una forma rotonda., il DNA si spezza, phosphatidylserine si sposta dal interno della cellula verso l'esterno. Sottoposta a terapia di miltefosine i promastigote muiano lentamente. cfr http://aac.asm.org/cgi/content/abstract/48/3/852

Antimicrobial Agents and Chemotherapy, March 2004, p. 852-859, Vol. 48, No. 3 0066-4804/04/$08.00+0 DOI: 10.1128/AAC.48.3.852-859.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved. Miltefosine Induces Apoptosis-Like Death in Leishmania donovani Promastigotes Caroline Paris, 1 Philippe M. Loiseau, 1* Christian Bories, 1 and Jaqueline Bréard 2* UMR 8076 CNRS, Chimiothérapie Antiparasitaire, 1 INSERM U461, Récepteurs et Signalisation des Interleukines, Faculté de Pharmacie Paris-Sud, 92290 ChÂtenay-Malabry, France 2 Received 21 July 2003/ Returned for modification 24 October 2003/ Accepted 31 October 2003 This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Cited by other online articles Books from ASM Press PubMed Miltefosine (hexadecylphosphocholine [HePC]) has proved to be a potent oral treatment for human visceral leishmaniasis due to Leishmania donovani. The molecular mechanisms that contribute to the antileishmanial activity of HePC are still unknown. We PubMed Citation Articles by Paris, C. Articles by Bréard, J. report that in wild-type promastigotes of Leishmania donovani HePC is able to induce a cell death process with numerous cytoplasmic, nuclear, and membrane features of metazoan apoptosis, including cell shrinkage, DNA fragmentation into oligonucleosome-sized fragments, and phosphatidylserine exposure. None of these changes were detected in an HePC-resistant clone treated with the same drug concentration. Therefore, HePC does not appear to kill L. donovani promastigotes by a direct toxic mechanism but, rather, kills the promastigotes by an indirect one. Pretreatment of wild-type promastigotes with two broad caspase inhibitors, z-val-ala-dl- Asp(methoxy)-fluoromethylketone and Boc-Asp(methoxy)-fluoromethylketone, as well as a broad protease inhibitor, calpain inhibitor I, prior to drug exposure interfered with DNA fragmentation but did not prevent cell shrinkage or phosphatidylserine externalization. These data suggest that at least part of the apoptotic machinery operating in wild-type promastigotes involves proteases. Identification of the death-signaling pathways activated in HePC-sensitive parasites appears to be essential for a better understanding of the molecular mechanisms of action and resistance in these parasites. * Corresponding author. Mailing address for Philippe M. Loiseau: UMR 8076 CNRS, Faculté de Pharmacie Paris-Sud, 5 rue Jean-Baptiste Clément, 92290 ChÂtenay-Malabry, France. Phone: (33)

1 46 83 55 53. Fax: (33) 1 46 83 55 57. E-mail: philippe.loiseau@cep.u-psud.fr. Mailing address for Jacqueline Bréard: INSERM U461, Faculté de Pharmacie Paris-Sud, 5 rue Jean-Baptiste Clément, 92290 ChÂtenay-Malabry, France. Phone: (33) 1 46 83 57 81. Fax: (33) 1 46 83 54 96. E- mail: jacqueline.breard@cep.u-psud.fr. Antimicrobial Agents and Chemotherapy, March 2004, p. 852-859, Vol. 48, No. 3 0066-4804/04/$08.00+0 DOI: 10.1128/AAC.48.3.852-859.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved. This article has been cited by other articles: Rakotomanga, M., Saint-Pierre-Chazalet, M., Loiseau, P. M. (2005). Alteration of Fatty Acid and Sterol Metabolism in Miltefosine-Resistant Leishmania donovani Promastigotes and Consequences for Drug-Membrane Interactions. Antimicrob. Agents Chemother. 49: 2677-2686 [Abstract] [Full Text] Verma, N. K., Dey, C. S. (2004). Possible Mechanism of Miltefosine-Mediated Death of Leishmania donovani. Antimicrob. Agents Chemother. 48: 3010-3015 [Abstract] [Full Text]